[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
INDICES> Revision of WHO/EDL: What should be deleted?
- From: richardl@bu.edu
- Date: Sun, 4 Aug 2002 09:31:46 -0400 (EDT)
INDICES>Revision of WHO/EDL: What should be deleted?
----------------------------------------------------------
I wonder how many Indices members saw the following message from Phil
Whiffen. [reproduced below; WB]
I would really encourage INDICES members to ask for the list and to
send in your comments.
Who thinks that chloral hydrate, trimthoprim
injection, folic acid injection, reserpine injection still belong on the
list?
This may also be a useful class excercise for anyone teaching a class on
drug information. You could set your class an assignment to review the
evidence for having the fifty or so drugs on the WHO list. The deadline is
rather short so I hope that many centers will take up the challenge and
respond quickly.
Otherwise the WHO Model EDL will continue to get longer as nothing gets
kicked off!
Richard Laing
Associate Professor of International Health
Boston University School of Public Health
715 Albany St, T4W, Boston MA 02118 USA
Tel 617 414-1444 Fax 617 638-4476
E-mail richardl@bu.edu
E-drug: Updating the WHO essential medicine list
-------------------------------------------------------------------------
Items are being considered for review at the next WHO Expert meeting in
March 2003. I have been asked by WHO to co-ordinate some of the work and a
list has been compiled of items which are considered to be of doubtful
efficacy,
have safety concerns or do not appear on a number of national essential
drug
lists. The list has been sent to a number of people who have been involved
with the project in the past and comments are also invited from the wider
e-drug list membership. If you would like to comment on this list of some
50
items please email me at phil.wiffen@pru.ox.ac.uk. I will then forward a
Word
document electronically. The deadline for returns is August 10th 2002
--
Phil Wiffen
Regional Pharmaceutical Adviser SERO UK
Co-ordinating Editor Cochrane Pain & Palliative Care Group
OXFORD UK
Tel +44 1865 225762
fax +44 1865 225400
phil.wiffen@pru.ox.ac.uk
--
To send a message to Indices, write to: indices@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe indices OR unsubscribe indices
To contact a person, send a message to: indices-help@usa.healthnet.org
Information and archives: http://www.healthnet.org/programs/indices.html
|